Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Current Leases (2023 - 2025)

Historic Current Leases for Pharma (IGC) over the last 3 years, with Q3 2025 value amounting to $9000.0.

  • Pharma's Current Leases fell 9328.36% to $9000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $9000.0, marking a year-over-year decrease of 9328.36%. This contributed to the annual value of $94000.0 for FY2025, which is 2419.35% down from last year.
  • According to the latest figures from Q3 2025, Pharma's Current Leases is $9000.0, which was down 9328.36% from $62000.0 recorded in Q2 2025.
  • Over the past 5 years, Pharma's Current Leases peaked at $134000.0 during Q3 2024, and registered a low of $9000.0 during Q3 2025.
  • Its 3-year average for Current Leases is $104111.1, with a median of $124000.0 in 2023.
  • Its Current Leases has fluctuated over the past 5 years, first changed by 0.0% in 2024, then tumbled by 9328.36% in 2025.
  • Over the past 3 years, Pharma's Current Leases (Quarter) stood at $124000.0 in 2023, then changed by 0.0% to $124000.0 in 2024, then plummeted by 92.74% to $9000.0 in 2025.
  • Its Current Leases stands at $9000.0 for Q3 2025, versus $62000.0 for Q2 2025 and $94000.0 for Q1 2025.